Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Juniper Pharmaceuticals Inc (NASDAQ:JNP)

4.55
Delayed Data
As of Sep 25
 -0.10 / -2.15%
Today’s Change
3.65
Today|||52-Week Range
6.40
-18.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues11.6M20.9M11.2M14.0M
 
 
 
 
 
Cost of Goods Sold5.2M5.3M6.1M7.1M
 
 
 
 
 
Depreciation And Amortization469.0K464.0K484.0K591.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.9M15.2M4.7M6.3M
 
 
 
 
 
General Expenses5.7M6.0M6.1M6.7M
 
 
 
 
 
Research And Development2.3M1.4M1.3M1.6M
 
 
 
 
 
Total Operating Expenses11.4M11.8M12.7M14.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income177.0K9.1M-1.5M-356.0K
 
 
 
 
 
Interest Expense On Debt24.0K23.0K28.0K30.0K
 
 
 
 
 
Other Expenses90.0K564.0K42.0K10.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income243.0K9.7M-1.4M-376.0K
 
 
 
 
 
Income Taxes-5.0K-44.0K0.000.00
 
 
 
Preferred Dividend-7.0K-7.0K-7.0K-452.0K
 
 
 
 
 
Net Income248.0K9.6M-1.4M-376.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.8M10.8M10.8M10.8M
 
 
 
 
 
Shares To Calculate EPS Diluted11.1M10.9M10.8M11.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.02$0.88-$0.13-$0.03
 
 
 
 
 
EPS Diluted$0.02$0.88-$0.13-$0.03